Wen Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wen Shi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Shuqin Chen
Department of Gynecology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3 shared publications Xiao Li
Department of Gynecology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
3 shared publicationsHuiling Lai
Department of Gynecology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
2 shared publicationsJinbo Li
Department of Gynecology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
2 shared publicationsMinyi Wang
Department of Gynecology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
2 shared publicationsQiyu Zhong
Department of Gynecology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-2
Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Response to Letter]
Response to Letter in regards to Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Letter]
- 1 April 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-2
Open AccessMetabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Response to Letter]
Response to Letter in regards to Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis [Letter]
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-23
Metabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis
Endometriosis (EMS) is characterized by pain symptoms that seriously affect patients’ quality of life. Gut microbiome-related metabolites (GMRM) play an important role in the process of EMS. However, the role of GMRM in endometrial stem cells and EMS-related pain remains unclear. An untargeted metabolomics approach was employed to analyze the fecal samples of 10 healthy individuals (heal), 11 EMS patients without dysmenorrhea (pless), and 14 EMS patients with dysmenorrhea (pain). The impact of potential key metabolite sakuranin on EMS-related pain was further investigated in vitro and in vivo. We identified 33 metabolites that were commonly changed in the painful group compared to the health and pless groups, and these metabolites were associated with differential microorganisms. Among them, sakuranin was downregulated in the painful group and exhibited a notably inverse correlation with the degree of pain. ROC curve revealed that sakuranin had a relatively high predictive value for EMS-related pain (AUC=0.8027). Functionally, sakuranin inhibited differentiation, migration, and inflammatory cytokine production, and decreased the expression of VEGF and ALCAM in SUSD2-positive primary endometrial cells. In EMS mice, sakuranin suppressed ectopic lesion growth, reduced inflammation, modulated angiogenesis and proliferation markers (VEGF, ALCAM, Ki-67), and regulated sympathetic and sensory nerve markers, resulting in alleviated pain behaviors. We delineated the metabolic landscape related to EMS-related pain and uncovered that sakuranin has the potential to inhibit the growth of EMS and alleviate EMS-related pain. This finding offers therapeutic strategies of sakuranin in alleviating the pain symptoms associated with EMS.
- 1 February 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-23
Open AccessMetabolomics Analysis Reveals Gut Microbiota-Associated Sakuranin Modulates Endometrial Stem Cell Differentiation and Inflammation to Alleviate Pain in Endometriosis
Endometriosis (EMS) is characterized by pain symptoms that seriously affect patients’ quality of life. Gut microbiome-related metabolites (GMRM) play an important role in the process of EMS. However, the role of GMRM in endometrial stem cells and EMS-related pain remains unclear. An untargeted metabolomics approach was employed to analyze the fecal samples of 10 healthy individuals (heal), 11 EMS patients without dysmenorrhea (pless), and 14 EMS patients with dysmenorrhea (pain). The impact of potential key metabolite sakuranin on EMS-related pain was further investigated in vitro and in vivo. We identified 33 metabolites that were commonly changed in the painful group compared to the health and pless groups, and these metabolites were associated with differential microorganisms. Among them, sakuranin was downregulated in the painful group and exhibited a notably inverse correlation with the degree of pain. ROC curve revealed that sakuranin had a relatively high predictive value for EMS-related pain (AUC=0.8027). Functionally, sakuranin inhibited differentiation, migration, and inflammatory cytokine production, and decreased the expression of VEGF and ALCAM in SUSD2-positive primary endometrial cells. In EMS mice, sakuranin suppressed ectopic lesion growth, reduced inflammation, modulated angiogenesis and proliferation markers (VEGF, ALCAM, Ki-67), and regulated sympathetic and sensory nerve markers, resulting in alleviated pain behaviors. We delineated the metabolic landscape related to EMS-related pain and uncovered that sakuranin has the potential to inhibit the growth of EMS and alleviate EMS-related pain. This finding offers therapeutic strategies of sakuranin in alleviating the pain symptoms associated with EMS.
- Open Access
- 31 October 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (11)
Deciphering the Pain-Related Gut Microbiome in Patients With Endometriosis
Background: Endometriosis (EMS), which affects >10% of women, is characterized by painful symptoms, such as dysmenorrhea. Meanwhile, the gut microbiota is linked to EMS; however, the relationship between the gut microbiota and EMS-related pain remains unclear. Methods: This study conducted 16S rRNA sequencing on fecal samples from 20 patients with EMS and dysmenorrhea, 13 patients with EMS but not dysmenorrhea, and 12 healthy controls. Results: Carbohydrate antigen 125 (CA125) levels were significantly higher in patients with EMS and dysmenorrhea. No significant differences in α- and β-diversity values were observed among the three groups (p > 0.05). However, Proteobacteria and Subdoligranulum showed increased abundance trends in patients with EMS and dysmenorrhea. Acinetobacter and Colidextribacter were less abundant in patients with EMS and dysmenorrhea than in those without dysmenorrhea (p < 0.05). Faecalicoccus pleomorphus and its genus also showed consistent depletion. At the genus level, a correlation analysis of the differential microbes revealed that UCG_005 and UCG_002 were central nodes in the correlation network (p < 0.05). Functional prediction indicated significant enrichment in cofactor and vitamin metabolism pathways in the EMS group with dysmenorrhea (p < 0.05). Several differential microbes, such as Faecalicoccus, Colidextribacter, and Acinetobacter, were negatively correlated with pain severity. Receiver operating characteristic curve analysis identified 10 microbial species with moderate diagnostic potential (area under the curve >0.7) for discriminating patients with EMS and dysmenorrhea, notably Ligilactobacillus. Conclusions: These results highlight distinct microbial alterations and functional pathways associated with EMS-related pain, suggesting potential diagnostic biomarkers for this condition.
- 31 October 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (11)
Open AccessDeciphering the Pain-Related Gut Microbiome in Patients With Endometriosis
Background: Endometriosis (EMS), which affects >10% of women, is characterized by painful symptoms, such as dysmenorrhea. Meanwhile, the gut microbiota is linked to EMS; however, the relationship between the gut microbiota and EMS-related pain remains unclear. Methods: This study conducted 16S rRNA sequencing on fecal samples from 20 patients with EMS and dysmenorrhea, 13 patients with EMS but not dysmenorrhea, and 12 healthy controls. Results: Carbohydrate antigen 125 (CA125) levels were significantly higher in patients with EMS and dysmenorrhea. No significant differences in α- and β-diversity values were observed among the three groups (p > 0.05). However, Proteobacteria and Subdoligranulum showed increased abundance trends in patients with EMS and dysmenorrhea. Acinetobacter and Colidextribacter were less abundant in patients with EMS and dysmenorrhea than in those without dysmenorrhea (p < 0.05). Faecalicoccus pleomorphus and its genus also showed consistent depletion. At the genus level, a correlation analysis of the differential microbes revealed that UCG_005 and UCG_002 were central nodes in the correlation network (p < 0.05). Functional prediction indicated significant enrichment in cofactor and vitamin metabolism pathways in the EMS group with dysmenorrhea (p < 0.05). Several differential microbes, such as Faecalicoccus, Colidextribacter, and Acinetobacter, were negatively correlated with pain severity. Receiver operating characteristic curve analysis identified 10 microbial species with moderate diagnostic potential (area under the curve >0.7) for discriminating patients with EMS and dysmenorrhea, notably Ligilactobacillus. Conclusions: These results highlight distinct microbial alterations and functional pathways associated with EMS-related pain, suggesting potential diagnostic biomarkers for this condition.